Sign In
Buy TOMDF
$0.000001
+0 (+0%)
At Close: Jun 02, 2026
Todos Medical says its CLIA/CAP lab Provista Diagnostics enters two new coronavirus PCR testing reference lab contracts
11:18am, Tuesday, 07'th Dec 2021
Todos Medical Ltd has said its CLIA/CAP lab Provista Diagnostics subsidiary has entered two new coronavirus (COVID-19) PCR reference testing contracts from laboratories collecting samples in Georgia
Todos Medical to Present at Upcoming Emerging Growth Conference
03:14pm, Monday, 06'th Dec 2021
New York, NY, and Tel Aviv, ISRAEL, Dec. 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today a
Todos Medical says all 31 patients in Tollovir Phase 2 clinical trial in hospitalized coronavirus patients have completed the study
08:23am, Thursday, 02'nd Dec 2021
Todos Medical Ltd revealed that all 31 patients enrolled to date in the Tollovir Phase 2 clinical trial in hospitalized coronavirus (COVID-19) patients in Israel have completed their participation in
Todos Medical to Host Business Update Conference Call on December 2nd at 4:30 PM EST
04:05pm, Wednesday, 01'st Dec 2021
New York, NY, and Tel Aviv, ISRAEL, Dec. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related solu
Todos Medical confirms SARS-CoV-2 PCR test kits used at its Provista lab can detect Omicron variant
11:55am, Tuesday, 30'th Nov 2021
Todos Medical Ltd has confirmed that the PCR test kits utilized at its Provista Diagnostics lab can detect a SARS-CoV-2 infection caused by the Omicron variant as well as all other variants. The com
Todos Medical Ltd said it has struck an agreement with NLC Pharma to acquire its 3CL protease biology-related assets and form a subsidiary to be known as 3CL Sciences. The subsidiary will focus on dev
Todos Medical Ltd, together with its 3CL protease biology-focused joint venture partner NLC Pharma Ltd, announced that it has received an initial purchase order from its European distribution partner
Todos Medical pauses enrollment for Tollovir Phase 2 clinical trial of coronavirus patients to study interim analysis data
10:50am, Friday, 19'th Nov 2021
Todos Medical Ltd has announced an update regarding the ongoing clinical development of Tollovir, its oral antiviral 3CL protease inhibitor and anti-cytokine therapeutic candidate to treat coronavirus
Todos Medical in the business of saving lives with early disease detection
09:30am, Thursday, 18'th Nov 2021
Develops proprietary technology for blood-based disease testing Offers a comprehensive suite of coronavirus (COVID-19) testing solutions Developing significant programs in cancer and Alzheimer's diagn
Todos Medical strikes exclusive license and distribution agreement for Tollovid products with T-Cell Protect Hellas SA
09:27am, Thursday, 18'th Nov 2021
Todos Medical Ltd, together with its joint venture partner NLC Pharma Ltd., announced that it has forged an exclusive European licensing and distribution agreement with T-Cell Protect Hellas SA for a
Todos Medical strikes new reference lab deal for Provista Diagnostics; ends 3Q with $1.01M in revenue
11:22am, Tuesday, 16'th Nov 2021
Todos Medical Ltd announced that its CLIA/CAP laboratory Provista Diagnostics has entered into a new reference lab agreement with an Atlanta-based CLIA laboratory to provide coronavirus (COVID-19) tes
Todos Medical says its Provista lab seeing significant increase in COVID-19 PCR testing volume with new automation
10:31am, Tuesday, 02'nd Nov 2021
Todos Medical Ltd has announced that its wholly owned CLIA/CAP-certified laboratory Provista Diagnostics is seeing a significant increase in coronavirus (COVID-19) PCR testing volume with its new au
Todos Medical announces 2nd site for Tollovir Phase 2 clinical trial for the treatment of hospitalized coronavirus patients
07:54pm, Monday, 01'st Nov 2021
Todos Medical, Ltd. has announced it is now adding the Hillel Yaffe Medical Center in Hadera as the second clinical trial site in Israel for its ongoing Tollovir Phase 2 randomized, double-blind, plac
Todos Medical, Ltd. has announced the publication of an article in the peer-reviewed scientific journal Nature Neuroscience by researchers at the University of Lübeck in Germany which has positive im
Todos Medical says journal article highlights utility of combining cPass and PCR testing to reduce COVID-19 transmission
11:42am, Thursday, 21'st Oct 2021
Todos Medical Ltd has announced the publication of an article entitled “A Practical Approach to SARS-CoV-2 Testing in Pre and Post Vaccination Era” in the peer-reviewed Journal of Clinical Virolog
